Organ Assist
Organ Assist is a Dutch medical technology company founded in 2005 that develops ex vivo organ perfusion and preservation devices and solutions for kidney, liver, and emerging heart transplantation, serving transplantation clinics and hospitals via direct enterprise sales of capital equipment and consumables.
- Company typePrivate
- Founded2005
- HeadquartersGroningen, Netherlands
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Organ Assist does
Organ Assist is a Dutch medical technology company founded in 2005 and headquartered in Groningen, the Netherlands, that develops ex vivo organ perfusion and preservation technology for transplantation medicine. Its core products include portable perfusion devices and protocols for kidneys (Kidney Assist Transport) and livers (Liver Assist), enabling hypothermic pulsatile perfusion, normothermic and sub-normothermic protocols, and dual hypothermic oxygenated perfusion (HOPE/DHOPE) with oxygenated solutions for up to 24-hour preservation and assessment. The company also has a heart preservation device in clinical study (US PRESERVE CAP study), and supports its installed base with disposable kits, perfusion solutions, and related accessories.
The company sells capital equipment and consumables to transplantation centers and hospitals primarily through direct enterprise sales with quote-based, multi-year contracts. Recurring revenue is generated from disposables and preservation solutions tied to each transplant procedure performed on the installed device base, layered on top of larger initial hardware placements. Organ Assist's buyer set is concentrated among tertiary medical centers performing kidney, liver, and emerging heart transplant procedures, and its GTM relies on clinical evidence, training programs, and direct engagement with transplant clinicians.
The company has raised capital from DFZ Participaties and MedSciences Capital (a 2010 round of approximately $2.3 million and a subsequent 2018 round), is led by CEO Wilfred den Hartog with founder Gerhard Rakhorst and CTO Arjan van der Plaats, and operates with 11-50 employees. Its growth trajectory is anchored on expansion of its installed base in transplantation centers, regulatory clearance of its heart preservation product, and entry into the US market via the PRESERVE CAP study.
Organ Assist firmographics
Firmographics- Name
- Organ Assist
- Website
- https://organ-assist.nl
- Company type
- Private
- Founded year
- 2005
- Headcount range
- 11–50 employees
- Short description
- Organ Assist is a Dutch medical technology company founded in 2005 that develops ex vivo organ perfusion and preservation devices and solutions for kidney, liver, and emerging heart transplantation, serving transplantation clinics and hospitals via direct enterprise sales of capital equipment and consumables.
- Ownership category
- akta.pro rank
Organ Assist industry classification
Industry- Product category
- Organ Perfusion Medical Devices
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)
Keywords
Where Organ Assist is headquartered
LocationHeadquarters
- HQ city
- Groningen
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Organ Assist business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Organ Perfusion Devices and Hardware: Sale of perfusion devices including XPS, Kidney Assist Transport, Liver Assist, and related disposable kits. These are medical devices sold to transplantation centers and hospitals.
- Preservation Solutions and Disposables: Sale of preservation solutions like PERFADEX Plus and STEEN Solution, as well as disposable kits for perfusion procedures. These are consumable products that generate recurring revenue.
- Organ Recovery and Perfusion Services: Full-service NRP (Normothermic Regional Perfusion) services including technology, logistics, staffing and support for organ recovery operations.
- XVIVO Insights Platform: Data and insights platform for organ perfusion monitoring and analysis, available via mobile app (iOS and Android)
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for hospitals and transplantation clinics |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Organ Assist product offering
Product offeringCore offering
Organ Assist develops and manufactures ex vivo organ perfusion devices and technologies used by transplant teams to preserve, transport, and assess donor kidneys and livers outside the body. Its product portfolio includes portable hypothermic pulsatile perfusion devices (Kidney Assist Transport) and configurable liver perfusion systems (Liver Assist) that support multiple protocols including HOPE, DHOPE, normothermic, and sub-normothermic perfusion. The company supplies transplant centers and hospitals with hardware, disposable kits, and preservation solutions to extend organ viability and improve transplantation outcomes.
Product overview
XVIVO offers a comprehensive portfolio of organ preservation and perfusion technologies for kidneys, livers, and lungs. The product suite includes machine perfusion devices (Kidney Assist Transport, Liver Assist, XPS for lungs), preservation solutions (PERFADEX Plus for lungs, STEEN Solution), and supporting components and consumables. Services include organ recovery and perfusion services, XVIVO Insights software platform, and training via XVIVO Academy. The company positions itself as a full-service provider enabling clinicians to preserve, transport and assess organs outside the body.
Differentiator
Problem solved
Functional benefit
Products and services
- Kidney Assist Transport A portable medical device that enables hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours, supporting extended preservation and viability assessment for transplant teams.
- Kidney Assist A machine perfusion device used for kidney preservation by transplant clinicians.
- Liver Assist A liver perfusion device that gives clinicians a choice of perfusion protocols including hypothermic (HOPE or DHOPE), normothermic, sub-normothermic, or dual hypothermic oxygenated perfusion for liver preservation and assessment.
Quantifiable outcome
- Reduction in waitlist mortality through increased organ utilization
Companies that use Organ Assist
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles1 record
Organ Assist technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Organ Assist partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- OrganOx LimitedcoreIn March 2025, UK-based OrganOx Limited partnered with US-based Procure On Demand Ltd. to improve donor liver recovery and transplantation services by combining OrganOx's normothermic machine perfusion technology with Procure On Demand's surgical team and service network. While not a direct XVIVO partnership, this represents the broader competitive landscape in the normothermic perfusion market where XVIVO operates.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Organ Assist competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks5 records
Key highlights5 records
Customer concentration
Organ Assist social profiles
Digital presenceOrgan Assist financial estimates
Financial estimateRevenue estimate
Valuation estimate
Organ Assist leadership team
Management profileNumber of profiles
Profiles3 records
Organ Assist funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Organ Assist M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Organ Assist
What does Organ Assist do?
Organ Assist develops and manufactures ex vivo organ perfusion devices and technologies used by transplant teams to preserve, transport, and assess donor kidneys and livers outside the body. Its product portfolio includes portable hypothermic pulsatile perfusion devices (Kidney Assist Transport) and configurable liver perfusion systems (Liver Assist) that support multiple protocols including HOPE, DHOPE, normothermic, and sub-normothermic perfusion. The company supplies transplant centers and hospitals with hardware, disposable kits, and preservation solutions to extend organ viability and improve transplantation outcomes.
When was Organ Assist founded?
Organ Assist was founded in 2005. It employs 11 to 50 people.
Where is Organ Assist based?
Organ Assist is headquartered in Groningen, Netherlands, in the Europe region.
How does Organ Assist make money?
Four revenue lines are on record. Organ Perfusion Devices and Hardware is the primary driver. The others are preservation Solutions and Disposables, organ Recovery and Perfusion Services and XVIVO Insights Platform.
Does Organ Assist have an API?
No public API is recorded for Organ Assist.
What industry is Organ Assist in?
Organ Assist's product category is Organ Perfusion Medical Devices. Its primary akta.pro industry code is HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO). Its NAICS code is 621991 and its SIC code is 3841.